Evidence map›Paper›PMID 15618187›Full record

ArticleInfection and immunity2005

CCL20/macrophage inflammatory protein 3alpha and tumor necrosis factor alpha production by primary uterine epithelial cells in response to treatment with lipopolysaccharide or Pam3Cys.

Mardi A Crane-Godreau, Charles R Wira

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract.American journal of reproductive immunology (New York, N.Y. : 1989) · 2009
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mardi A Crane-GodreauDepartment of Physiology, Dartmouth Medical School, Borwell Building, 1 Medical Center Dr., Lebanon, NH 03756, USA. Mardi.Crane@Dartmouth.edu
Charles R Wira

Funding

The influence of steroid sex hormones and gender on pmnP01AI051877 · NIAID · DARTMOUTH COLLEGE · PI WIRA, CHARLES ROBERT · 2002 to 2006
$7.4M
SEX HORMONE REGULATION OF THE MUCOSAL IMMUNE SYSTEMR37AI013541 · NIAID · DARTMOUTH COLLEGE · PI WIRA, CHARLES ROBERT · 1997 to 2005
$2.1M
SEX HORMONE REGULATION OF THE MUCOSAL IMMUNE SYSTEMR01AI013541 · NIAID · DARTMOUTH COLLEGE · PI WIRA, CHARLES ROBERT · 1985 to 2011
$2.0M
SEX HORMONE REGULATION OF THE MUCOSAL IMMUNE SYSTEMR55AI013541 · NIAID · DARTMOUTH COLLEGE · PI WIRA, CHARLES ROBERT · 1991 to 1991
–
NIAID NIH HHS AI-13541NIAID NIH HHS AI-51877NIAID NIH HHS P01 AI051877NIAID NIH HHS R01 AI013541NIAID NIH HHS R37 AI013541
6 · The paper itself

Abstract

Having previously shown that CCL20/macrophage inflammatory protein 3alpha and tumor necrosis factor alpha (TNF-alpha) are released by polarized primary rat uterine epithelial cells (UEC) in response to Escherichia coli but not to Lactobacillus rhamnosus, we sought to determine if epithelial cells are responsive to pathogen-associated molecular patterns (PAMP), including lipopolysaccharide (LPS), lipoteichoic acid (LTA), and Pam(3)Cys, a bacterial lipoprotein analog. Epithelial cells were grown to confluence on Nunc cell culture inserts prior to apical treatment with PAMPs. In response to LPS, LTA, and Pam(3)Cys (EMC Microcollection GmbH, Tubingen, Germany), CCL20 levels increased (4- to 10-fold) while PAMPs caused increased TNF-alpha (1- to 4-fold) in the medium collected after 24 h of incubation. Both apical and basolateral secretion of CCL20 and TNF-alpha increased in response to PAMPs, but treatments had no effect on cell viability and integrity, as measured by transepithelial resistance. Time course studies of CCL20 and TNF-alpha release in response to Pam(3)Cys and LPS indicated that CCL20 release peaked between 2 and 4 h after treatment, whereas TNF-alpha release was gradual over the length of the incubation. Freeze-thaw and cell lysis experiments, along with actinomycin D studies, suggested that CCL20 and TNF-alpha are synthesized in response to PAMP stimulation. Taken together, these studies demonstrate that E. coli and selected PAMPs have direct effects on the production of CCL20 and TNF-alpha without affecting cell integrity. Since CCL20 is known to be both chemotactic and antimicrobial, the increase in apical and basolateral release by UEC in response to PAMPs suggests a new mechanism of innate immune protection in the female reproductive tract.

Indexed as

AnimalsCell PolarityCells, CulturedChemokine CCL20Chemokines, CCCysteineDactinomycinEpithelial CellsFemaleLipopolysaccharidesLipoproteinsMacrophage Inflammatory ProteinsMembrane GlycoproteinsRatsRats, Inbred LewReceptors, Cell Surface2,3-bis(palmitoyloxy)-2-propyl-1-palmitoylcysteineCcl20 protein, ratChemokine CCL20Chemokines, CCCysteineDactinomycinLipopolysaccharidesLipoproteinslipoteichoic acidMacrophage Inflammatory ProteinsMembrane GlycoproteinsReceptors, Cell SurfaceTeichoic AcidsToll-Like ReceptorsTumor Necrosis Factor-alpha

Identifiers

PMID15618187
PMCPMC538962
OpenAlexW2158127984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.